Olanzapine

Spécifications

132539-06-1Numéro CAS

603-618-4Numéro CE

2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepineNom IUPAC

C17H20N4SFormule chimique

312.4 g/molMasse molaire

olanzapine; 132539-06-1; Olansek; Zyprexa Zydis; Zalasta; Zyprexa Velotab; Zyprexa Intramuscular; olanzapina; Olanzapine Mylan; LY-170053; 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine; Olazax; Olanzapine Teva; Olazax Disperzi; Olanzapine Glenmark; olanzapinum; LY 170053; Olanzapine cipla; Olanzapine apotex; 10H-thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-; Olanzapin; DTXSID9023388; LY170053; Olanzapine Glenmark Europe; N7U69T4SZR; 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine; CHEBI:7735; DTXCID503388; LYBALVI COMPONENT OLANZAPINE; 10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-; Arkolamyl; 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno(2,3-b)(1,5)benzodiazepine; RefChem:6083; N05AH03; LY170052; LY 170052; 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo(8.4.0.03,7)tetradeca-1(14),3(7),5,8,10,12-hexaene; Deprex; Zyprexa; 2-Methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine; Olzapin; Lanzac; C17H20N4S; Zolafren; Oferta; 2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine; MFCD00866702; CHEMBL715; Olanzapine D3; NCGC00096077-03; Midax; 2-Methyl-4-(4-methyl-1-piperazinyl)- 10H-thieno[2,3-b][1,5]benzodiazepine; Olanzapine Teva; SMR000466345; Olanzapine Neopharma; Olanzapine ( 1.0 mg/mL in Acetonitrile); CAS-132539-06-1; SR-01000759343; UNII-N7U69T4SZR; Olanzapine?; Zolafren;; Zalasta;; Zyprexa;; Olanzapine CRS; Zyprexa Zydis;; ALKS-7921; HSDB 8155; Olanzapine [USAN:USP:INN:BAN]; Olanzapine; 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; LY 170053; Lanzac; Zyprexa; KS-1090; PS15 - Olanzapine; Olanzapine (Standard); OLANZAPINE [MI]; OLANZAPINE [INN]; OLANZAPINE [JAN]; OLANZAPINE [USAN]; OLANZAPINE [VANDF]; GTPL47; OLANZAPINE [MART.]; OLANZAPINE [USP-RS]; OLANZAPINE [WHO-DD]; BIDD:PXR0138; SCHEMBL28763; Olanzapine (JAN/USP/INN); US8802672, Olanzapine; MLS000759457; MLS001165781; MLS001195646; MLS001424057; BIDD:GT0332; OLANZAPINE [EMA EPAR]; SCHEMBL117695; SPECTRUM1505024; Olanzapine (LY-170053); orb1226541; orb1308151; orb3141183; OLANZAPINE [ORANGE BOOK]; Olanzapine, >=98% (HPLC); SCHEMBL29358280; BDBM35254; BDBM82479; CHEBI:94534; OLANZAPINE [EP MONOGRAPH]; GLXC-02527; HMS2051H05; HMS2089M04; HMS2093I04; HMS2233F24; HMS3374L02; HMS3393H05; HMS3657I15; HMS3714J03; HMS3743A09; HMS3884J21; HMS5081A13; OLANZAPINE [USP MONOGRAPH]; SYMBYAX COMPONENT OLANZAPINE; ALBB-027265; LGB68679; MSK10167; NSC_4585; Olanzapine, 1mg/ml in Acetonitrile; Tox21_111556; AC-665; EBC-06991; HB1786; HY-14541R; NSC754829; NSC801187; s2493; STK634338; STL388024; Olanzapine for system suitability CRS; 2-methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[3,2-c][1,5]benzodiazepine; 2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine; AKOS000282888; AKOS005566122; Olanzapine 1.0 mg/ml in Acetonitrile; Tox21_111556_1; CCG-100922; CS-1114; DB00334; FO26537; NC00172; NSC-754829; NSC-801187; NCGC00096077-01; NCGC00096077-04; NCGC00096077-05; NCGC00096077-06; NCGC00096077-09; NCGC00096077-17; NCGC00096077-18; NCGC00096077-20; NCGC00389791-02; 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene; HY-14541; SBI-0206786.P001; CAS_132539-06-1; NS00000036; O0393; O4400; SW220248-1; C07322; D00454; EN300-119499; AB00639907-06; AB00639907-07; AB00639907_08; AB00639907_09; L000455; L005958; Q201872; SR-01000759343-4; SR-01000759343-6; BRD-K18895904-001-15-3; BRD-K18895904-001-16-1; BRD-K18895904-001-17-9; Z1521553472; Olanzapine, European Pharmacopoeia (EP) Reference Standard; Olanzapine, United States Pharmacopeia (USP) Reference Standard; Olanzapine, Pharmaceutical Secondary Standard; Certified Reference Material; 2-Methyl-10-(4-methyl-piperazin-1-yl)-4H-3-thia-4,9-diaza-benzo[f]azulene; 2-methyl-4-(4-methyl-1-piperazinyl) -10h-thieno[2,3-b][1,5]benzodiazepine; 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-[2,3-b][1,5]benzodiazepine; 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine #; 2-Methyl-4-(4-methylpiperazin-1-yl)-10H- thieno[2,3-b][1,5]benzodiazepin; Olanzapine for system suitability, European Pharmacopoeia (EP) Reference Standard; Olanzapine-d8, 100 mug/mL in acetonitrile, ampule of 1 mL, certified reference material; 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0,3,7]tetradeca-1(10),3(7),5,8,11,13-hexaene; Olanzapine MicronizedSynonymes